September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluating the Response of Type 1 Choroidal Neovasular Membrane in Neovascular Age-Related Macular Degeneration to Anti-VEGF Treatment by Optical Coherence Tomography-Angiography
Author Affiliations & Notes
  • Ching Jygh Chen
    Ophthal & Visual Science, Univ of Mississippi Med Center, Jackson, Mississippi, United States
  • Matt Olsen
    Ophthal & Visual Science, Univ of Mississippi Med Center, Jackson, Mississippi, United States
  • Brian Tieu
    Ophthal & Visual Science, Univ of Mississippi Med Center, Jackson, Mississippi, United States
  • Jordan Burnham
    Ophthal & Visual Science, Univ of Mississippi Med Center, Jackson, Mississippi, United States
  • Footnotes
    Commercial Relationships   Ching Chen, None; Matt Olsen, None; Brian Tieu, None; Jordan Burnham, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1625. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Ching Jygh Chen, Matt Olsen, Brian Tieu, Jordan Burnham; Evaluating the Response of Type 1 Choroidal Neovasular Membrane in Neovascular Age-Related Macular Degeneration to Anti-VEGF Treatment by Optical Coherence Tomography-Angiography. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1625.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the response of Type 1 CNV in neovascular ARMD to anti-VEGF treatment using OCT angiography (OCTA)

Methods : Retrospective review of SSADA-based OCTA images from patients treated with anti-VEGF for neovascular ARMD with type 1 CNV.

Results : 37 eyes with type 1 CNV were treated with various anti-VEGF agents. Among them, 10 remained partially active; 7 were refractive to treatment; 10 were responsive with temporary inactivity; and 10 were quiescent for more than one year after treatment. The OCTA detected blood flow in all 37 treated CNVs. In partially active CNV, the size and vascular volume of the CNV varied. The size of the CNV was smaller in partially active and temporarily inactive CNVs compared to refractive CNVs. The CNV responded to anti-VEGF treatment by partial closure of peripheral vascular branches, but the central vascular trunk remained unaffected. Recurrent activity also involved mainly the peripheral branches. In refractive CNV, weekly OCTA showed no to minimal vascular responses. In quiescent CNV, flow change analysis showed a steady vascular flow pattern without changes.

Conclusions : Blood flow was detected by OCTA in all treated CNVs regardless of their clinical response to anti-VEGF treatment. The treatment goal for neovascular ARMD should not be a complete resolution of the CNV. Instead, the main aim may be turning an exudative type to a non-exudative CNV. The role of OCTA alone in the management of neovascular ARMD still needs further study.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×